MANAGEMENT, ECONOMIC AND SOCIAL IMPACT OF SUB-CUTANEOUS RITUXIMAB ADMINISTRATION IN DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) AND FOLLICULAR LYMPHOMA (FL)

被引:0
|
作者
Annibali, O. [1 ]
Tomarchio, V. [1 ]
Becilli, M. [1 ]
Sarlo, C. [1 ]
Proietti, R. [1 ]
Tafuri, M. [1 ]
Ioele, D. [2 ]
Ferraro, S. [1 ]
Bolettieri, A. [3 ]
Tafuro, G. [4 ]
Berti, P. [1 ]
Avvisati, G. [1 ]
机构
[1] Univ Campus Bio Med Roma, UOC Ematol Trapianto Cellule Staminali, Rome, Italy
[2] Univ Campus Bio Med Roma, Area Farm, Rome, Italy
[3] Univ Campus Bio Med Roma, Area Informat, Rome, Italy
[4] Univ Campus Bio Med Roma, Area Controllo & Gest, Rome, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P154
引用
收藏
页码:113 / 113
页数:1
相关论文
共 50 条
  • [21] Phase I dose escalation of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
    Batlevi, Connie Lee
    Hamlin, Paul A.
    Matasar, Matthew J.
    Horwitz, Steven M.
    Gerecitano, John F.
    Moskowitz, Craig H.
    Straus, David J.
    Zelenetz, Andrew David
    Drullinsky, Pamela
    Copeland, Amanda
    Ahsanuddin, Salma
    Callan, Devin
    Freidin, Benjamin
    Porzio, Robert
    Dang, Thu Oanh
    Ni, Ai
    Rademaker, Jurgen
    Schoder, Heiko
    Dogan, Ahmet
    Younes, Anas
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [22] Outcomes of cardiac diffuse large B-cell lymphoma (DLBCL) in the rituximab era
    Al-Juhaishi, Taha
    Al-Kindi, Sadeer G.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 339 : 146 - 149
  • [23] Combinatorial Targeting of BCL6 and Anti-Apoptotic Proteins in Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)
    Dupont, Thibault
    Dong, Zhenghong
    Yang, ShaoNing
    Melnick, Ari
    Cerchietti, Leandro
    BLOOD, 2012, 120 (21)
  • [24] Diffuse large B-cell lymphoma (DLBCL)
    Renner, C.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 82 : S10 - S10
  • [25] Diffuse Large B Cell Lymphoma Coexistent with Follicular Cell Lymphoma
    Zhang, Ling
    Wang, Xiaozhen
    Cheng, Na
    Zhang, Jingwen
    Fang, Zhigang
    Long, Bing
    Lin, Dongjun
    CLINICAL LABORATORY, 2018, 64 (7-8) : 1311 - 1315
  • [26] Risk and clinical implications of transformation of follicular lymphoma (FL) to diffuse large cell B-cell lymphoma (tFL).
    Montoto, S
    Davies, AJ
    Matthews, J
    Calaminici, M
    Norton, AJ
    Amess, J
    Vinnicombe, S
    Rohatiner, AZS
    Lister, A
    BLOOD, 2005, 106 (11) : 179A - 179A
  • [27] A Cross-Sectional Study of Unmet Needs of Lymphoma Patients in Patient-Doctor Communication: Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL)
    Bamigbola, Olufunmilayo A.
    Dren, Natalie M.
    Warwick, Lorna E.
    BLOOD, 2019, 134
  • [28] EPIDEMIOLOGICAL DATA OF VENEZUELAN PATIENTS WITH LYMPHOMA. IMPROVEMENT OF THE OUTCOME OF FOLLICULAR LYMPHOMA (FL) AND DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) WITH R-CHOP VS CHOP
    Mueller, A.
    Morales, M.
    Acquatella, G.
    Torres, M.
    Reboso, C.
    Tovar, E.
    Chiquin, D.
    Villegas, M.
    Soyano, A.
    Guevara, M.
    Noriega, N.
    Croce, N.
    Capote, L.
    HAEMATOLOGICA, 2012, 97 : 672 - 672
  • [29] Management of DLBCL (Diffuse Large B-Cell Lymphoma): A Monocentric Experience
    Tlohi, Kawtar
    Benmoussa, Amine
    Harrach, Asmaa
    Lamchahab, Mouna
    Rachid, Mohamed
    Khoubila, Nissrine
    Cherkaoui, Siham
    Qachouh, Meryem
    Mandani, Abdellah
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S431 - S431
  • [30] Follicular Lymphoma with Transition to a Diffuse Large B-Cell-Lymphoma
    Vetter-Kauczok, C. -S.
    Geissinger, E.
    Broecker, E. -B.
    Becker, J. -C.
    AKTUELLE DERMATOLOGIE, 2007, 33 (12) : 475 - 477